Several malignant tumors are unique to infants and children. Earlier diagnosis, improved surgical techniques, and recent developments in radiotherapy have increased overall survival rates. Chemotherapeutic agents have likewise played a major role in providing cure, long-term survival, or patient comfort. An aggressive treatment program that combines all 3 modes of therapy and that is based on controlled clinical studies should continue to improve the outlook for these unfortunate children with malignant disease.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً